Schedule 13G ownership disclosure

CITIUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 17322U207

Event date: 2019-05-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-003846
Form type
SC 13G
Filer
Citius Pharmaceuticals, Inc.
CIK
CIK 1506251
Filed
May 28, 2019
Reporting period
May 21, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub